Synergistic anticancer activity of resveratrol in combination with docetaxel in prostate carcinoma cells
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
BACKGROUND/OBJECTIVES: The study was conducted to investigate the efficacy of the combination treatment of phytochemical resveratrol and the anticancer drug docetaxel (DTX) on prostate carcinoma LNCaP cells, including factors related to detailed cell death mechanisms. MATERIALS/METHODS: Using 2-dimensional monolayer and 3-dimensional spheroid culture systems, we examined the effects of resveratrol and DTX on cell viability, reactive oxygen species (ROS) levels, mitochondrial membrane potential, apoptosis, and necroptosis by MTT, flow cytometry, and Western blotting. RESULTS: At concentrations not toxic to normal human prostate epithelial cells, resveratrol effectively decreased the viability of LNCaP cells depending on concentration and time. The combination treatment of resveratrol and DTX exhibited synergistic inhibitory effects on cell growth, demonstrated by an increase in the sub-G0/G1 peak, Annexin V-phycoerythrin positive cell fraction, ROS, mitochondrial dysfunction, and DNA damage response as well as concurrent activation of apoptosis and necroptosis. Apoptosis and necroptosis were rescued by pretreatment with ROS scavenger N-acetylcysteine. CONCLUSIONS: We report resveratrol as an adjuvant drug candidate for improving the outcome of treatment in DTX therapy. Although the underlying mechanisms of necroptosis should be investigated comprehensively, targeting apoptosis and necroptosis simultaneously in the treatment of cancer can be a useful strategy for the development of promising drug candidates.
Abstract
BACKGROUND/OBJECTIVES: The study was conducted to investigate the efficacy of the combination treatment of phytochemical resveratrol and the anticancer drug docetaxel (DTX) on prostate carcinoma LNCaP cells, including factors related to detailed cell death mechanisms. MATERIALS/METHODS: Using 2-dimensional monolayer and 3-dimensional spheroid culture systems, we examined the effects of resveratrol and DTX on cell viability, reactive oxygen species (ROS) levels, mitochondrial membrane potential, apoptosis, and necroptosis by MTT, flow cytometry, and Western blotting. RESULTS: At concentrations not toxic to normal human prostate epithelial cells, resveratrol effectively decreased the viability of LNCaP cells depending on concentration and time. The combination treatment of resveratrol and DTX exhibited synergistic inhibitory effects on cell growth, demonstrated by an increase in the sub-G0/G1 peak, Annexin V-phycoerythrin positive cell fraction, ROS, mitochondrial dysfunction, and DNA damage response as well as concurrent activation of apoptosis and necroptosis. Apoptosis and necroptosis were rescued by pretreatment with ROS scavenger N-acetylcysteine. CONCLUSIONS: We report resveratrol as an adjuvant drug candidate for improving the outcome of treatment in DTX therapy. Although the underlying mechanisms of necroptosis should be investigated comprehensively, targeting apoptosis and necroptosis simultaneously in the treatment of cancer can be a useful strategy for the development of promising drug candidates.
참고문헌 (36)
- War AR, "Mechanisms of plant defense against insect herbivores", Plant Signal Behav, 7, pp.1306~1320 (2012)
- Salehi B, "Resveratrol : a double-edged sword in health benefits", Biomedicines, 6, pp.91~ (2018)
- Ko JH, "The role of resveratrol in cancer therapy", Int J Mol Sci, 18, pp.2589~ (2017)
- Takashina M, "Different effect of resveratrol to induction of apoptosis depending on the type of human cancer cells", Int J Oncol, 50, pp.787~797 (2017)
- Hu S, "The synergistic effect of resveratrol in combination with cisplatin on apoptosis via modulating autophagy in A549 cells", Acta Biochim Biophys Sin(Shanghai), 48, pp.528~535 (2016)
- Chang TW, "Synergistic combinations of tanshinone IIA and trans-resveratrol toward cisplatin-comparable cytotoxicity in HepG2 human hepatocellular carcinoma cells", Anticancer Res, 34, pp.5473~5480 (2014)
- Kai L, "Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells", Anticancer Res, 31, pp.3323~3330 (2011)
- Singh SK, "Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53", p21WAF1, Oncotarget, pp.2017, 8[DOI]
- Sharma A, "Cancer metabolism and the evasion of apoptotic cell death", Cancers(Basel), 11, pp.1144~ (2019)
- Zong WX, "Necrotic death as a cell fate", Genes Dev, 20, pp.1~15 (2006)
- Su Z, "Cancer therapy in the necroptosis era", Cell Death Differ, 23, pp.748~756 (2016)
- Gong Y, "The role of necroptosis in cancer biology and therapy", Mol Cancer, 18, pp.100~ (2019)
- Adachi I, "A late phase II study of RP56976(docetaxel)in patients with advanced or recurrent breast cancer", Br J Cancer, 73, pp.210~216 (1996)
- Hernández-Vargas H, "Telling cells how to die : docetaxel therapy in cancer cell lines", Cell Cycle, 6, pp.780~783 (2007)
- Bayat Mokhtari R, "Combination therapy in combating cancer", Oncotarget, 8, pp.38022~38043 (2017)
- Tsakalozou E, "Combination effects of docetaxel and doxorubicin in hormone-refractory prostate cancer cells", Biochem Res Int, 2012, pp.832059~ (2012)
- Petrylak DP, "Docetaxel for the treatment of hormone-refractory prostate cancer", Rev Urol, 5(Suppl 2), pp.S14~S21 (2003)
- Savarese DM, "Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer : a final report of CALGB 9780", J Clin Oncol, 19, pp.2509~2516 (2001)
- Budman DR, "Synergistic and antagonistic combinations of drugs in human prostate cancer cell lines in vitro", Anticancer Drugs, 13, pp.1011~1016 (2002)
- Lee YJ, "Synergistic anti-cancer effects of resveratrol and chemotherapeutic agent clofarabine against human malignant mesothelioma MSTO-211H cells", Food Chem Toxicol, 52, pp.61~68 (2013)
- Chambers KF, "3D cultures of prostate cancer cells cultured in a novel high-throughput culture platform are more resistant to chemotherapeutics compared to cells cultured in monolayer", PLoS One, 9, pp.e111029~ (2014)
- Eguchi Y, "Intracellular ATP levels determine cell death fate by apoptosis or necrosis", Cancer Res, 57, pp.1835~1840 (1997)
- Bray K, "Bcl-2 modulation to activate apoptosis in prostate cancer", Mol Cancer Res, 7, pp.1487~1496 (2009)
- Zhang XQ, "Apogossypolone, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces autophagy of PC-3 and LNCaP prostate cancer cells in vitro", Asian J Androl, 12, pp.697~708 (2010)
- Wang X, "RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway", Nat Immunol, 15, pp.1126~1133 (2014)
- Wang H, "Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3", Mol Cell, 54, pp.133~146 (2014)
- Chen W, "Diverse sequence determinants control human and mouse receptor interacting protein 3(RIP3)and mixed lineage kinase domain-like(MLKL)interaction in necroptotic signaling", J Biol Chem, 288, pp.16247~16261 (2013)
- Cheung-Ong K, "DNA-damaging agents in cancer chemotherapy : serendipity and chemical biology", Chem Biol, 20, pp.648~659 (2013)
- Schmitt E, "DNA-damage response network at the crossroads of cell-cycle checkpoints, cellular senescence and apoptosis", J Zhejiang Univ Sci B, 8, pp.377~397 (2007)
- Pearl LH, "Therapeutic opportunities within the DNA damage response", Nat Rev Cancer, 15, pp.166~180 (2015)
- Borges HL, "DNA damage-induced cell death : lessons from the central nervous system", Cell Res, 18, pp.17~26 (2008)
- Schulze-Osthoff K, "Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation", J Biol Chem, 267, pp.5317~5323 (1992)
- Redza-Dutordoir M, "Activation of apoptosis signalling pathways by reactive oxygen species", Biochim Biophys Acta, 1863, pp.2977~2992 (2016)
- Holmström KM, "Cellular mechanisms and physiological consequences of redox-dependent signalling", Nat Rev Mol Cell Biol, 15, pp.411~421 (2014)
- Qian Q, "Targeting reactive oxygen species in cancer via Chinese herbal medicine", Oxid Med Cell Longev, 2019, pp.9240426~ (2019)
- Zanoni M, "3D tumor spheroid models for in vitro therapeutic screening : a systematic approach to enhance the biological relevance of data obtained", Sci Rep, 6, pp.19103~ (2016)